The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Embedded outpatient palliative care for hematologic malignancies: Referral patterns and health care utilization.
 
Mazie Tsang
Stock and Other Ownership Interests - AVEO; Poseida Therapeutics
Other Relationship - National Institute on Aging
 
Kara E. Bischoff
No Relationships to Disclose
 
Kelly L. Schoenbeck
Employment - Doximity (I)
Stock and Other Ownership Interests - Doximity (I)
Research Funding - American Society of Hemotology (Inst)
 
Kim Berry
No Relationships to Disclose
 
David O'Riordan
No Relationships to Disclose
 
Bita Fakhri
No Relationships to Disclose
 
Sandy Wai Kuan Wong
Consulting or Advisory Role - Sanofi
Research Funding - Bristol Myers Squibb (Inst); Caelum Biosciences (Inst); Fortis (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Patented Medicine Prices Review Board (Inst); Roche/Genentech (Inst)
 
Nina Shah
Consulting or Advisory Role - Amgen; CareDX; CSL Behring; Genentech/Abbvie; GlaxoSmithKline; Indapta Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Oncopeptides; Sanofi
Research Funding - Bluebird Bio; Celgene; Cellectis; Janssen; Nektar; poseida therapeutics; Precision Biosciences; Sutro biopharma; Teneobio
 
Eve Cohen
No Relationships to Disclose
 
Nancy Shepard Lopez
No Relationships to Disclose
 
Gabriel N. Mannis
Consulting or Advisory Role - Abbvie/Genentech; Agios; Astellas Pharma; Bristol-Myers Squibb/Celgene; Forty Seven; Macrogenics; SERVIER; Stemline Therapeutics
Research Funding - Astex Pharmaceuticals (Inst); Forty Seven (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Immune-Onc Therapeutics (Inst); Jazz Pharmaceuticals (Inst); Syndax (Inst)
 
Michael W. Rabow
No Relationships to Disclose